Notice of Application - 2003

FR Doc 03-17123 [Federal Register: July 8, 2003 (Volume 68, Number 130)] [Notices] [Page 40686] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr08jy03-88]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 8, 2003, Cody Laboratories, Inc., made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Diphenoxylate (9170)--Schedule II 
Meperidine (9230)--Schedule II 
Oxymorphone (9652)--Schedule II 
Sufentanil (9740)--Schedule II

The firm plans to manufacture bulk material for distribution to its customers. 

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

 Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than September 8, 2003.

Laura M. Nagel, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [

FR Doc. 03-17123 Filed 7-7-03; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).